Lonza

In 1897, in the quaint Swiss village of Gampel, Albrecht Gansser and Dr. August Kleiber embarked on a venture that would eventually become a cornerstone of the pharmaceutical and biotechnology industries. They founded Lonza, named after the nearby river, initially focusing on producing electricity for the textile industry.

Over the decades, Lonza evolved, expanding its expertise and services. By the mid-20th century, the company had diversified into chemical manufacturing, setting the stage for its future as a leader in life sciences. This transformation was marked by strategic shifts and a commitment to innovation, allowing Lonza to adapt to the changing demands of the global market.

A pivotal moment in Lonza's history came in 1999 when the company went public, listing on the Swiss Stock Exchange. This move not only provided the capital needed for further expansion but also solidified Lonza's position as a key player in the global market.

Today, Lonza stands as a multinational powerhouse, providing critical development and manufacturing services to the pharmaceutical, biotechnology, and nutrition sectors. Its journey from a small Swiss town to a global leader underscores the impact of strategic foresight and adaptability in the ever-evolving landscape of life sciences.